Earnings Call/Transcript
Colgate-Palmolive (India) Investor Day 2026 Transcript
Colgate-Palmolive (India) Ltd filed the transcript of its Investor Day 2026 held on 2026-08-17; transcript is available on the company's website.

Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.



Personal Products
Personal Care
51,404 Cr
Low Risk
38.1
41.9
4.0
32.5
2,505.00
1,781.60
Sales CAGR
Profit CAGR
ROE
ROCE
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
Colgate-Palmolive (India) Ltd (COLPAL) is currently trading at 1,877.00 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Colgate-Palmolive (India) Limited is a leading provider of oral care products, offering toothpastes, toothpowder, toothbrushes, and mouthwashes under the 'Colgate' brand, alongside personal care products under 'Palmolive'. The company ended FY 2024-25 with a revenue of Rs. 5,999 crores, marking a 6.3% growth driven by strong performances in toothpaste and toothbrush categories. EBITDA margins stood at 32.6%. An intense focus on premiumization and innovation led to successful launches like the Colgate Visible White Purple and Max Fresh Sensorials, contributing to sustainable volume growth, especially in premium segments. Significant urban-rural disparities exist, with rural areas showing robust growth contrary to urban slowing, especially in the lower 70% income segment. Premium category growth continues to be strong in urban areas. Colgate's strategic initiative 'Oral Health Movement' engaged 4.5 million consumers, leveraging technology for oral health assessments, contributing to a vast database for oral care insights in India.
Over the past 52 weeks, Colgate-Palmolive (India) Ltd has traded between a low of ₹1,781.60 and a high of ₹2,505.00. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Colgate-Palmolive (India) Ltd has a market capitalization of approximately 51,403.92. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Colgate-Palmolive (India) Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 38.14 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 51,403.92 Cr, Colgate-Palmolive (India) Ltd is classified as a Mid Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Colgate-Palmolive (India) Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Colgate-Palmolive (India) Ltd is 38.14. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
The board meeting to consider and approve unaudited Q1 FY27 results is scheduled for July 29, 2026, for the quarter ended June 30, 2026.
Revenue rose 11.8% year-on-year to ₹1,603 crore, compared with ₹1,434 crore in the base quarter.
Net profit was ₹320.62 crore for the quarter ended June 2025 (Q1 FY26), down 12% year-on-year from ₹363.98 crore.
Nomura upgraded the stock from ‘Reduce’ to ‘Buy’ and raised its target to ₹2,500, citing improving volume trends and expectations of better FY27 earnings growth.
Bearish
3
Neutral
4
Bullish
7
Bearish
35
Neutral
4
Bullish
7
Bearish
32
Neutral
0
Bullish
0
Bearish
3
Neutral
4
Bullish
7
Bearish
3
Neutral
4
Bullish
7
Bearish
32
Neutral
0
Bullish
0
Bearish
32
Neutral
0
Bullish
0
Bearish
32
Neutral
0
Bullish
0

Earnings Call/Transcript
Colgate-Palmolive (India) Ltd filed the transcript of its Investor Day 2026 held on 2026-08-17; transcript is available on the company's website.
Earnings Call/Transcript
Colgate-Palmolive (India) filed the transcript of its Investor Day 2026 held on 2026-08-17; transcript and presentation are available on the company website.
Change in Directors/KMP
Colgate-Palmolive (India) announced resignation of MD & CEO Prabha Narasimhan effective close of business on 2026-09-27 and appointment of Manish Anandani as MD & CEO from 2026-09-28 for five years, subject to approvals.
Change in Directors/KMP
Colgate-Palmolive (India) announced MD & CEO Prabha Narasimhan will resign effective 2026-09-27; Manish Anandani approved as new MD & CEO effective 2026-09-28 for 5 years, subject to shareholder and statutory approvals.
Change in Directors/KMP
Colgate-Palmolive (India) Ltd board accepted Prabha Narasimhan's resignation effective Sep 27, 2026 and approved appointment of Manish Anandani as MD & CEO from Sep 28, 2026 for five years, subject to shareholder and statutory approvals.
Change in Directors/KMP
Colgate-Palmolive (India) Ltd: Board accepted Ms. Prabha Narasimhan's resignation as MD & CEO effective 2026-09-27 and approved appointment of Mr. Manish Anandani as MD & CEO effective 2026-09-28, subject to shareholder/statutory approvals.